The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125869731 12586973 1 I 20160712 20160725 20160725 EXP US-JNJFOC-20160717094 JANSSEN REAGAN PM, BARAN A, KELLY JL, PAUL BM, CASULO C, CHENGAZI VU, ET AL. CONSOLIDATIVE RADIOIMMUNOTHERAPY AFTER CHEMOIMMUNOTHERAPY IN PATIENTS WITH HISTOLOGIC TRANSFORMATION OF INDOLENT NON-HODGKIN LYMPHOMA. CLIN LYMPHOMA MYELOMA LEUK 01-JUN-2016;16 (6):322-328.E2. 70.00 YR E M Y 0.00000 20160725 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125869731 12586973 1 PS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) N 50718 LIPOSOME INJECTION
125869731 12586973 2 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown 0 UNSPECIFIED
125869731 12586973 3 SS VINCRISTINE VINCRISTINE 1 Unknown 0 UNSPECIFIED
125869731 12586973 4 SS PREDNISONE. PREDNISONE 1 Unknown 0 UNSPECIFIED
125869731 12586973 5 SS RITUXIMAB RITUXIMAB 1 Unknown 0 UNSPECIFIED
125869731 12586973 6 SS YTTRIUM 90 IBRITUMOMAB TIUXETAN IBRITUMOMAB TIUXETAN 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125869731 12586973 1 B-cell lymphoma
125869731 12586973 2 B-cell lymphoma
125869731 12586973 3 B-cell lymphoma
125869731 12586973 4 B-cell lymphoma
125869731 12586973 5 B-cell lymphoma
125869731 12586973 6 B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
125869731 12586973 OT
125869731 12586973 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125869731 12586973 Acute myeloid leukaemia
125869731 12586973 Anaemia
125869731 12586973 Neutropenia
125869731 12586973 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found